Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Gene: Crim1 (cysteine rich transmembrane BMP regulator 1) Rattus norvegicus
Analyze
Symbol: Crim1
Name: cysteine rich transmembrane BMP regulator 1
Description: Predicted to have PDZ domain binding activity. Predicted to be involved in negative regulation of endopeptidase activity. Predicted to localize to the extracellular region and integral component of membrane. Orthologous to human CRIM1 (cysteine rich transmembrane BMP regulator 1); INTERACTS WITH (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE; 17alpha-ethynylestradiol; 17beta-estradiol.
Type: protein-coding
RefSeq Status: VALIDATED
Also known as: cysteine rich transmembrane BMP regulator 1 (chordin like); cysteine-rich motor neuron 1; LOC298744
Orthologs:
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rnor_6.06788,490 - 962,663 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.06780,568 - 954,493 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.46962,024 - 1,141,314 (+)NCBIRGSC3.4rn4RGSC3.4
RGSC_v3.161,051,003 - 1,141,914 (+)NCBI
Celera616,341,369 - 16,513,685 (-)NCBICelera
Cytogenetic Map6q11NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene-Chemical Interaction Annotations
Gene Ontology Annotations
References - curated
References - uncurated

Genomics

Comparative Map Data
Position Markers
QTLs in Region (Rnor_6.0)
miRNA Target Status

Sequence

Nucleotide Sequences
Protein Sequences
Transcriptome
Promoters

Strain Variation

Strain Sequence Variants (Rnor 6.0)
Damaging Variants

Additional Information

External Database Links
Nomenclature History
 
More on Crim1
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

RGD Object Information
RGD ID: 1308710
Created: 2005-01-12
Species: Rattus norvegicus
Last Modified: 2019-08-20
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.